We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.36B
AUM Growth
+$77.6M
Cap. Flow
+$46.1M
Cap. Flow %
3.39%
Top 10 Hldgs %
13.88%
Holding
1,633
New
514
Increased
325
Reduced
386
Closed
373

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$14.2M
2
DOMO icon
Domo
DOMO
+$12.7M
3
NFLX icon
Netflix
NFLX
+$12.4M
4
EA
Electronic Arts
EA
+$12.3M
5
DAY
Dayforce
DAY
+$11.5M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$17.1M
2
COOP
Mr. Cooper
COOP
+$13.5M
3
K
Kellanova
K
+$11.9M
4
LITE icon
Lumentum
LITE
+$9.69M
5
IBIT icon
iShares Bitcoin Trust
IBIT
+$9.44M

Sector Composition

Rank Sector Weight
1 Technology 23.27%
2 Healthcare 13.54%
3 Communication Services 10.55%
4 Consumer Discretionary 9.61%
5 Industrials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STX icon
26
Seagate
STX
$184B
$7.93M 0.58%
28,808
+12,175
+73% +$3.16M
TSLA icon
27
Tesla
TSLA
$1.3T
$7.81M 0.57%
17,356
+13,917
+405% +$6.17M
SRLN icon
28
State Street Blackstone Senior Loan ETF
SRLN
$5.34B
$7.77M 0.57%
188,330
+8,103
+4% +$335K
WDC icon
29
Western Digital
WDC
$150B
$7.05M 0.52%
40,917
+8,466
+26% +$1.28M
ATXS
30
DELISTED
Astria Therapeutics
ATXS
$6.92M 0.51%
+529,021
New +$6.32M
AMZN icon
31
Amazon
AMZN
$2.96T
$6.92M 0.51%
29,985
-37,573
-56% -$8.6M
JOYY
32
JOYY Inc
JOYY
$3.75B
$6.9M 0.51%
106,592
+4,500
+4% +$275K
CLS icon
33
Celestica
CLS
$36.5B
$6.67M 0.49%
22,571
+2,802
+14% +$844K
CDTX
34
DELISTED
Cidara Therapeutics
CDTX
$6.33M 0.47%
+28,641
New +$4.63M
KVUE icon
35
Kenvue
KVUE
$36.9B
$6.22M 0.46%
+360,856
New +$5.9M
GTLS
36
DELISTED
Chart Industries
GTLS
$6.16M 0.45%
29,889
-13,263
-31% -$2.69M
CIEN icon
37
Ciena
CIEN
$58.4B
$6.07M 0.45%
25,963
+3,809
+17% +$739K
AIFC
38
AI Financial Corp
AIFC
$61.3M
$5.56M 0.41%
5,055,089
+2,744,329
+119% +$5.29M
TPB icon
39
Turning Point Brands
TPB
$1.74B
$5.44M 0.4%
50,183
-9,448
-16% -$924K
PCG icon
40
PG&E
PCG
$38.5B
$5.11M 0.38%
318,268
-6,527
-2% -$104K
CORZ icon
41
Core Scientific
CORZ
$6.75B
$5.11M 0.38%
351,156
+258,287
+278% +$4.5M
FOLD
42
DELISTED
Amicus Therapeutics
FOLD
$4.98M 0.37%
+349,414
New +$3.43M
CMA
43
DELISTED
Comerica
CMA
$4.95M 0.36%
+56,977
New +$4.59M
LLY icon
44
Eli Lilly
LLY
$1.06T
$4.94M 0.36%
4,600
+1,270
+38% +$1.21M
TSM icon
45
TSMC
TSM
$2.18T
$4.92M 0.36%
16,182
-5,878
-27% -$1.72M
GPK icon
46
Graphic Packaging
GPK
$3.58B
$4.89M 0.36%
324,997
+135,946
+72% +$2.23M
CNC icon
47
Centene
CNC
$32.5B
$4.89M 0.36%
118,717
+24,951
+27% +$934K
PLTR icon
48
Palantir
PLTR
$413B
$4.86M 0.36%
27,326
+18,297
+203% +$3.31M
PRAX icon
49
Praxis Precision Medicines
PRAX
$10.1B
$4.73M 0.35%
16,038
-12,064
-43% -$2.25M
LINC icon
50
Lincoln Educational Services
LINC
$1.3B
$4.67M 0.34%
193,411
+5,770
+3% +$126K
1
2
3 4 5

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Prelude Capital Management held 1,633 positions worth $1.36B, up 6.1% from $1.28B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management deployed $46.1M of net new capital in Q4 2025, opening 514 new positions and adding to 325 existing holdings. Its largest new stake was Nice: 117,600 shares worth $13.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Lumentum, an estimated $9.69M trimmed.

  • Prelude Capital Management's largest Q4 2025 buy was Nice: 117,600 shares worth $13.3M.
  • Prelude Capital Management added most to Domo in Q4 2025, an estimated $12.7M increase.
  • Prelude Capital Management's biggest Q4 2025 reduction was Lumentum, cutting an estimated $9.69M.
  • Prelude Capital Management fully exited Verona Pharma in Q4 2025, selling an estimated $17.1M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.36B portfolio in Q4 2025.
  • Prelude Capital Management opened 514 new positions and closed 373 in Q4 2025.
  • Prelude Capital Management's portfolio value rose 6.1% quarter-over-quarter to $1.36B.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.